Cboe Global Markets soars on strong Q1 beat, raised guidance By Investing.com

Cboe delivered a strong Q1 beat, with adjusted EPS of $3.70 topping the $3.25 consensus and revenue of $728.9 million exceeding estimates while rising 29% year over year. Management raised 2026 organic revenue growth targets to low double-digit to mid-teens, lifted Data Vantage growth guidance, and lowered adjusted operating expense guidance to $838-$853 million. The company also returned capital via a $0.72 dividend and repurchased about 161,000 shares, and the stock rose 4.3% on the report.

Analysis

Cboe’s print is less about a one-quarter beat and more about a credibility reset in the revenue mix: the business is demonstrating it can grow even if market volatility normalizes, because listed options activity, data, and international franchises are all compounding together. The most important second-order effect is that the market may now be underestimating the durability of data monetization; if Data Vantage is accelerating into the low-double digits while headcount falls ~20%, incremental margin leverage can become unusually strong over the next 2-4 quarters.

The bigger competitive implication is for exchange peers and market-data vendors that rely on a softer tape to drive pricing. Cboe’s strength suggests liquidity migration and options participation remain structurally elevated, which can pressure smaller venues and reinforce scale advantages at the top of the stack. The workforce reduction also matters: if execution risk stays contained, this is the kind of cost action that can re-rate the stock because the market tends to pay up for exchanges when growth is paired with visible margin discipline.

The contrarian risk is that the stock may already be pricing in a cleaner macro and sustained retail/institutional options demand, leaving it vulnerable if volatility and volumes revert faster than expected. The key watch item is whether the options growth is transaction-driven or structurally sticky; if ADV cools while pricing normalizes, top-line momentum could slow abruptly over 1-2 quarters. On the other hand, the buyback pace is still modest versus cash generation, so capital returns are supportive but not the core thesis.

Net: this is a quality compounder re-accelerating, but the cleaner trade may be through relative value rather than outright momentum. The setup favors a medium-horizon long if guidance revisions continue, but the asymmetric risk is a disappointment in market activity, not a fundamental balance-sheet issue.

Key Decisions for Investors

• Stay long CBOE on a 3-6 month horizon; use pullbacks after the initial earnings gap as better entry points. Risk/reward is attractive if management converts guidance into 2-3 successive quarters of margin expansion, but trim if options ADV decelerates materially.
• Pair long CBOE / short ICE or NDAQ for relative outperformance over the next 1-2 quarters if options and data growth remain the dominant drivers. The thesis is that CBOE’s mix is more levered to structural volume plus cost actions, while the short leg is more exposed to broader market-data skepticism.
• Buy CBOE call spreads 2-4 months out, targeting upside continuation from further guide-up revisions. This is preferable to outright shares if volatility is elevated, with defined downside if the market fades the earnings beat.
• Avoid chasing the post-print move if you are looking for a tactical trade; wait for confirmation in the next monthly options/volatility prints. The stock is likely to be most vulnerable to any sign that the growth acceleration was partially front-loaded.
• If you want a contrarian hedge, short a basket of exchange/data names with weaker cost discipline and slower organic growth. The relative trade benefits if investors continue to reward margin-accretive restructuring over passive revenue growth.